OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventive empagliflozin activity on acute acetic acid-induced ulcerative colitis in rats via modulation of SIRT-1/PI3K/AKT pathway and improving colon barrier
Marwa S. Zaghloul, Mahmoud Elshal, Marwa E. Abdelmageed
Environmental Toxicology and Pharmacology (2022) Vol. 91, pp. 103833-103833
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Formulation, Optimization, and Evaluation of Lornoxicam-Loaded Novasomes for Targeted Ulcerative Colitis Therapy: In Vitro and In Vivo Investigations
Asmaa Badawy Darwish, Abeer Salama, Inas Essam Ibrahim Al-Samadi
Journal of drug targeting (2025), pp. 1-21
Closed Access | Times Cited: 3

MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT
Jie Zhang, Cen Li, Xiaofen Zhang, et al.
Redox Biology (2022) Vol. 56, pp. 102469-102469
Open Access | Times Cited: 64

Mechanisms of SGLT2 Inhibitors in Heart Failure and Their Clinical Value
Yafei Xie, Yujie Wei, Dan Li, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 81, Iss. 1, pp. 4-14
Closed Access | Times Cited: 34

Sirtuin family in autoimmune diseases
Zhengjie Tao, Zihan Jin, Jiabiao Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26

The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation
H. Salman, Adeeb A. Al-Zubaidy, Alaa Hamza Abbas, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 13

Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors
Mona Mashayekhi, Bilgunay Ilkin Safa, Matthew S.C. Gonzalez, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 425-438
Closed Access | Times Cited: 9

Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access | Times Cited: 1

Genistein and/or sulfasalazine ameliorate acetic acid-induced ulcerative colitis in rats via modulating INF-γ/JAK1/STAT1/IRF-1, TLR-4/NF-κB/IL-6, and JAK2/STAT3/COX-2 crosstalk
Esraa A. Elhefnawy, Hala F. Zaki, Nabila N. El Maraghy, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115673-115673
Closed Access | Times Cited: 18

Eicosapentaenoic acid mitigates ulcerative colitis-induced by acetic acid through modulation of NF-κB and TGF-β/ EGFR signaling pathways
Raghda N. El Mahdy, Manar A. Nader, Manar G. Helal, et al.
Life Sciences (2023) Vol. 327, pp. 121820-121820
Closed Access | Times Cited: 17

Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats
Maha M. Abdel‐Fattah, Emad H.M. Hassanein, Ahmed M. Sayed, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 533-533
Open Access | Times Cited: 12

Phosphatidylinositol 3‐kinase signaling pathway and inflammatory bowel disease: Current status and future prospects
Abduladheem Turki Jalil, Nassef F. Hassan, Sada Jasim Abdulameer, et al.
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 5, pp. 910-917
Closed Access | Times Cited: 11

Rebamipide in gastric mucosal protection and healing: An Asian perspective
Manish Kak
World Journal of Gastrointestinal Pharmacology and Therapeutics (2025) Vol. 16, Iss. 1
Open Access

Mechanistic and Molecular Insights into Empagliflozin’s Role in Ferroptosis and Inflammation Trajectories in Acetaminophen-Induced Hepatotoxicity
Aisha Alhaddad, Esraa M. Mosalam, Hind S. AboShabaan, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 405-405
Open Access

Rivaroxaban loaded lipid carriers integrating EPA oil: A novel paradigm in drug repurposing for navigating colon targeted oral treatment for ulcerative colitis.
Walaa A. El‐Dakroury, Abdelrahman R. Said, Sherif S. Abdel Mageed, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106985-106985
Closed Access

Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression
Shaymaa S. Seoudi, Eman Allam, Amal H. El‐Kamel, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 11, pp. 2930-2947
Open Access | Times Cited: 8

Tiron ameliorates acetic acid-induced colitis in rats: Role of TGF-β/EGFR/PI3K/NF-κB signaling pathway
Raghda N. El Mahdy, Manar A. Nader, Manar G. Helal, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111587-111587
Closed Access | Times Cited: 2

Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism
Iman O. Sherif, Nora Hamad Al‐Shaalan, Walaa Awadin
Toxicology Research (2024) Vol. 13, Iss. 4
Closed Access | Times Cited: 2

Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway
Raghda N. El Mahdy, Manar A. Nader, Manar G. Helal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 2

Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function
Yifeng Wang, Jiawei Li, Da‐Peng Wang, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1697-1711
Open Access | Times Cited: 11

Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1/AKT/NF-κB signaling pathway
Lingya Yao, Xiaoli Chen, Manlu Shen, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109532-109532
Closed Access | Times Cited: 11

Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis
Adam Makaro, Mikołaj Świerczyński, Kacper Pokora, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 377-392
Open Access | Times Cited: 6

The emerging coloprotective effect of sildenafil against ulcerative colitis in rats via exerting counterbalance between NF-κB signaling and Nrf-2/HO-1 pathway
Ghada S. El‐Tanbouly, Rehab S. Abdelrahman
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1351-1362
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top